From:  The role of the resveratrol-sirtuin axis in the treatment of metabolic dysfunction-associated diseases

 Mechanisms of RSV-targeted SIRTs in the regulation of obesity.

RSV-targeted
SIRTS
Mechanisms of actionRegulation of substrates and pathwaysRoles in diseasesResearch objectsReferences
SIRT1↑SIRT1
↑FOXO1
↑ATGL
↑Lipolysis
↓Lipid accumulation
RSV activates SIRT1, restores the expression of FOXO1 and ATGL, and thereby reverses fat accumulation.Alleviates obesity by increasing lipid accumulation.Male Sprague-Dawley rats and 3T3-L1 preadipocytes[34]
SIRT1↑SIRT1
↑PGC-1α
↑NFR-1/PPAR/PXR/PAR
↑TFAM/UCP1
RSV activates SIRT1, increases the level of UCP protein expression and TFAM, thereby enhancing energy expenditure.Alleviates obesity by enhancing energy expenditure and thermogenesis.Rats[40]
SIRT1↑SIRT1
↓Akt2
↓mTORC1
↓p-mTOR
↓p-S6K1
↓Adipose inflammation
RSV inhibited adipose inflammation by activating the SIRT1/Akt2/mTOR/S6K1 pathway.Alleviates obesity by inhibiting lipid accumulation.Mice[35]
SIRT1↑4-HPA
↑SIRT1
↑PGC-1α/PPARγ/UCP1
↑Mitochondrial biogenesis
↑Browning of white adipocytes
↓Lipogenesis
RSV is metabolized by the gut microbiota to produce 4-HPA and related metabolites, which activate the expression of SIRT1 pathway genes.Inhibits obesity through gut microbiota-derived metabolic pathways.Male C57BL/6J mice[43]

4-HPA: 4-hydroxyphenylacetic acid; Akt2: protein kinase B 2; ATGL: adipose triglyceride lipase; FOXO1: forkhead box O1; mTORC1: mechanistic target of rapamycin complex 1; NFR-1: nuclear factor related-1; PAR: poly (ADP-ribose); PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-alpha; p-mTOR: phosphorylated mTOR; PPAR: peroxisome proliferator-activated receptor; p-S6K1: phosphorylated ribosomal protein S6 kinase beta-1; PXR: pregnane X receptor; RSV: resveratrol; SIRT: sirtuin; TFAM: mitochondrial transcription factor A; UCP: uncoupling protein.